Document is current

Article History

Received: 26 August 2025

Accepted: 19 November 2025

First Online: 15 December 2025

Declarations

:

: The University of Tasmania Human Research Ethics Committee reviewed and approved this study. All participants gave their informed consent. We confirm that we have read the journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.

: We provide the following additional financial disclosures for the past 3 years, which are unrelated to the current work:JA received grants from the National Health and Medical Research Council, Royal Hobart Hospital Research Foundation, Dementia Australia Research Foundation, Medical Protection Society Tasmania Ltd, speaker fees from STADA and AbbVie; support to attend medical meetings from AbbVie, Novo Nordisk, and the Global Parkinson’s Genetics Program (GP2); royalties from CRC Press for medical textbooks; a paid editorial role with npj Parkinson’s Disease; and holds stock in ClearSky Medical Diagnostics.AK received grants from FightMND, the Dementia Australia Research Foundation, and the Royal Hobart Hospital Research Foundation.AB received funding from the National Health and Medical Research Council, Monash University, and the Royal Hobart Hospital Research Foundation.LG received funding from the Medical Research Future Fund, the Royal Hobart Hospital Research Foundation, Aged Care Research & Industry Innovation, and Equity Trustees (Victoria).RL, KR, ER, KL, MA, CS, DM, JV, and QB have no additional declarations to make.